Automating Cell-Based Assays to Determine Viral Vector Titer

Analytical Methods in Gene Therapy - Case Study with Oxford Biomedica

Cover image for Hamilton case study on Oxford Biomedica cell and gene therapy automation

What’s in the Case Study?

In this Case Study, Oxford Biomedica, an innovative global gene and cell therapy company with operations in the UK and US, describes the automation of a 10-day cell-based workflow required for an analytical test to determine viral vector titer, using Hamilton Microlab® STAR™ liquid handlers.

Highlights of this Case Study

  • Detailed description of the automated system used for the cell-based workflow
  • Advantages of Hamilton's CECULA Graphical User Interface (GUI) for the planning of long-term cell-based assays
  • Transfer of the automated assay to Good Manufacturing Practice (GMP)

Read the full Case Study to learn more.